Cross-Sectional Guidelines for Therapy with Blood Components and Plasma Derivatives: Chapter 5 Human Albumin - Revised

Overview

Journal Transfus Med Hemother

Specialty Hematology

Date 2016 Jul 13

PMID 27403094

Citations 16

Affiliations

Soon will be listed here.

Abstract

Chapter 5 'Human Albumin' that was suspended on January 10, 2011 has been completed and updated in the present version.

Citing Articles

Association between serum IgG concentrations and the incidence of infections in patients with chronic lymphocytic leukemia and secondary immunodeficiency under treatment with Privigen.

Otremba B, Haslbauer F, Reiser M, Weide R, Obermeier M, Pfrunder D Int J Clin Pharmacol Ther. 2024; 62(6):241-249.

PMID: 38577752 PMC: 11112504. DOI: 10.5414/CP204473.

Anemia diagnosis and therapy in malignant diseases: implementation of guidelines-a representative study.

Link H, Kerkmann M, Holtmann L, Detzner M Support Care Cancer. 2024; 32(2):113.

PMID: 38240843 PMC: 10799088. DOI: 10.1007/s00520-023-08267-4.

A Narrative Literature Review of the Established Safety of Human Serum Albumin Use as a Stabilizer in Aesthetic Botulinum Toxin Formulations Compared to Alternatives.

Sattler S, Gollomp S, Curry A Toxins (Basel). 2023; 15(10).

PMID: 37888650 PMC: 10610632. DOI: 10.3390/toxins15100619.

Evaluation of the Effectiveness of Boron Neutron Capture Therapy with Iodophenyl-Conjugated -Dodecaborate on a Rat Brain Tumor Model.

Fujikawa Y, Fukuo Y, Nishimura K, Tsujino K, Kashiwagi H, Hiramatsu R Biology (Basel). 2023; 12(9).

PMID: 37759639 PMC: 10525593. DOI: 10.3390/biology12091240.

Carbon Nanotube-Incorporated Nanofibers for Immunosensor Preparation against CD36.

Zeybekler S, Odaci D ACS Omega. 2023; 8(6):5776-5786.

PMID: 36816687 PMC: 9933220. DOI: 10.1021/acsomega.2c07458.

References

Fleck A, Raines G, Hawker F, Trotter J, Wallace P, LEDINGHAM I . Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury. Lancet. 1985; 1(8432):781-4. DOI: 10.1016/s0140-6736(85)91447-3. View

Oganesyan V, Damschroder M, Cook K, Li Q, Gao C, Wu H . Structural insights into neonatal Fc receptor-based recycling mechanisms. J Biol Chem. 2014; 289(11):7812-24. PMC: 3953293. DOI: 10.1074/jbc.M113.537563. View

Fan E, Stewart T . Albumin in critical care: SAFE, but worth its salt?. Crit Care. 2004; 8(5):297-9. PMC: 1065031. DOI: 10.1186/cc2943. View

Groenland T, Porte R, Metselaar H . Liver transplantation and risk of bleeding. Curr Opin Organ Transplant. 2016; 12(3):287-293. DOI: 10.1097/MOT.0b013e32814e6bb0. View

Ferguson N, Stewart T, Etchells E . Human albumin administration in critically ill patients. Intensive Care Med. 1999; 25(3):323-5. DOI: 10.1007/s001340050844. View

Guthrie Jr R, Hines Jr C . Use of intravenous albumin in the critically ill patient. Am J Gastroenterol. 1991; 86(3):255-63. View

Whatling P . Intravenous fluids for abdominal aortic surgery. Cochrane Database Syst Rev. 2000; (4):CD000991. DOI: 10.1002/14651858.CD000991. View

Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R . A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004; 350(22):2247-56. DOI: 10.1056/NEJMoa040232. View

Roberts I, Blackhall K, Alderson P, Bunn F, Schierhout G . Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev. 2011; (11):CD001208. PMC: 7055200. DOI: 10.1002/14651858.CD001208.pub4. View

10.

Mobarhan S . The role of albumin in nutritional support. J Am Coll Nutr. 1988; 7(6):445-52. DOI: 10.1080/07315724.1988.10720260. View

11.

Perel P, Roberts I . Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2011; (3):CD000567. DOI: 10.1002/14651858.CD000567.pub4. View

12.

. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ. 1998; 317(7153):235-40. PMC: 28613. DOI: 10.1136/bmj.317.7153.235. View

13.

Martin-Llahi M, Pepin M, Guevara M, Diaz F, Torre A, Monescillo A . Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology. 2008; 134(5):1352-9. DOI: 10.1053/j.gastro.2008.02.024. View

14.

Finfer S, Bellomo R, McEvoy S, Lo S, Myburgh J, Neal B . Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ. 2006; 333(7577):1044. PMC: 1647335. DOI: 10.1136/bmj.38985.398704.7C. View

15.

Maitland K, Kiguli S, Opoka R, Engoru C, Olupot-Olupot P, Akech S . Mortality after fluid bolus in African children with severe infection. N Engl J Med. 2011; 364(26):2483-95. DOI: 10.1056/NEJMoa1101549. View

16.

Neri S, Pulvirenti D, Malaguarnera M, Cosimo B, Bertino G, Ignaccolo L . Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome. Dig Dis Sci. 2007; 53(3):830-5. DOI: 10.1007/s10620-007-9919-9. View

17.

Jacob M, Chappell D, Conzen P, Wilkes M, Becker B, Rehm M . Small-volume resuscitation with hyperoncotic albumin: a systematic review of randomized clinical trials. Crit Care. 2008; 12(2):R34. PMC: 2447554. DOI: 10.1186/cc6812. View

18.

Thomas-Rueddel D, Vlasakov V, Reinhart K, Jaeschke R, Rueddel H, Hutagalung R . Safety of gelatin for volume resuscitation--a systematic review and meta-analysis. Intensive Care Med. 2012; 38(7):1134-42. DOI: 10.1007/s00134-012-2560-x. View

19.

Himpe D . Colloids versus crystalloids as priming solutions for cardiopulmonary bypass: a meta-analysis of prospective, randomised clinical trials. Acta Anaesthesiol Belg. 2003; 54(3):207-15. View

20.

Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Castells L . Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999; 341(6):403-9. DOI: 10.1056/NEJM199908053410603. View